Exabis Library
Welcome to the e-CCO Library!
P714: Comparison of intestinal microbiota profiles of faecal samples, rectal swabs and mucosal biopsies in patients with Inflammatory Bowel Disease. A multicentre, observational study.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P714: Efficacy and safety of infliximab retreatment in luminal Crohn’s disease: a multi-centre, prospective, observational cohort (REGAIN) study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P714: Mucosal healing in CD with vedolizumab versus other biologics: endoscopic outcomes during long-term routine care in a multinational observational study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P714: Vedolizumab, an adequate option in medically refractory and thiopurine-intolerant inflammatory bowel disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P714: Vitamin D deficiency in inflammatory bowel disease: prevalence and relation to disease activity in a cohort of patients of a Mediterranean country
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P715 The prevalence of chronic musculoskeletal pain in patients with ulcerative colitis in comparison to control subjects: A cross-sectional study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P715: Achievement and maintenance of endoscopic, histologic, and combined outcomes after extended induction in Week 10 nonresponders of ozanimod: 2-year interim analysis of the True North open-label extension study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P715: Opioid use in patients with inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P715: Real-world tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P715: Selective enhancement of immune cell response to opportunistic microorganisms: An innovative proposal for Inflammatory Bowel Disease from an ancient grain.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P715: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease: results from a single-center in 2004, 2009 and 2014
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P716 Clinical significance of residual non-rectal inflammation in ulcerative colitis patients with clinical remission
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P716: A 2-week course of Exclusive Enteral Nutrition followed by the Crohn Disease Exclusion Diet is effective for Induction and Maintenance of Remission in children with Crohn Disease; the DIETOMICS-CD trial
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P716: Beta-blocker use is associated with a higher relapse risk of inflammatory bowel disease – a Dutch retrospective cohort study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P716: Current smoking trends in British IBD patients in the age of e-cigarettes
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P716: Exclusive Enteral Nutrition refurbishes beneficial gut microbiota in patients with Acute Severe Ulcerative Colitis
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P716: The use of tacrolimus in patients with ulcerative colitis resistant to standard medical therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P717 Ustekinumab in Crohn’s disease: Real-world outcomes from the Sicilian Network for inflammatory bowel diseases (SN-IBD):–Preliminary results
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P717: Comparison of two different techniques to assess vedolizumab trough levels in adult patients with IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P717: Faecal Microbiota Transplant in Ulcerative Colitis (FMTUC) – A randomised clinical trial feasibility study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM